TRIPS-plus and access to medicines in China

Journal of Public Health Policy

Volumn 34, Issue 2, 2013, Pages 226-238

  Chen, Jing ^a   Nie, Xiaoyan ^a   Yao, Peng ^a   Shi, Luwen ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Access to medicines; China; Public health; Trade; TRIPS plus

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; CHINA; DEVELOPING COUNTRY; DRUG INDUSTRY; ECONOMICS; HEALTH CARE DELIVERY; HUMAN; INTERNATIONAL COOPERATION; LEGAL ASPECT; PATENT;

CHINA; DEVELOPING COUNTRIES; DRUG INDUSTRY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTELLECTUAL PROPERTY; INTERNATIONAL COOPERATION; PRESCRIPTION DRUGS;

EID: 84877296680     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/jphp.2013.13     Document Type: Article

References (31)

1. Susan, K.S. (2011) TRIPS was never enough: Vertical forum shifting, FTAs, ACTA, and TPP. Journal of Intellectual Property Law 18(2): 447-478.
2. Malpani, R. (2007) All cost no benefit: How TRIPS-Plus intellectual property rules in the US-Jordan FTA affect access to medicines. Oxford, UK: Oxfam International. Oxfam Briefing Paper No. 102, http://donttradeourlivesaway. files.wordpress.com/2011/01/all-costs-no-benefits. pdf, accessed 19 February 2013.
3. Nusaraporn, K., Jiraporn, L., Vidhaya, K., Usawadee, M., Achara, E. and Prinya, P. (2010) Impact on access to medicines from TRIPS-PLUS:A case study of Thai-US FTA. Southeast Asian Journal of Tropical Medicine Public Health 41(3): 667-677.
4. United Nations. (2001)World Population Ageing 1950-2050. New York: Population Division, DESA, United Nations.
5. World Health Organization. (2011) Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: World Health Organization.
6. Ministry of Health of China, UNAIDS, WHO. (2010) The Estimation of HIV/AIDS in China in 2009. Beijing, China: Ministry of Health.
7. Ministry of Health of China. (2011) Statistics Report on Epidemic Situation of Legal Communicable Diseases in China in (2010). Beijing, China: Ministry of Health.
8. Lu, F. and Zhuang, H. (2009) Management of hepatitis B in China. Chinese Medical Journal 122(1): 3-4.
9. Ministry of Health of China. (2011) China Health Statistical Yearbook 2010. Beijing, China: Ministry of Health.
10. The Organisation for Economic Co-operation and Development. (2012) OECD health data 2012 - Frequently requested data, http://www.oecd.org/health/ healthpoliciesanddata/oecdhealthdata2012-frequentlyrequesteddata.htm, accessed 3 March 2012.
11. Epstein, R.J. (2007) Growth of the Asian health-care market: Global implications for the pharmaceutical industry. Nature Reviews Drug Discovery 6(10): 785-792. (Pubitemid 47500505)
12. World Bank. (2010) A Generic Drug Policy as Cornerstone to Essential Medicines in China. Washington DC: The World Bank, China Health Policy Notes No 4, http://siteresources .worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/ 281627-1285186535266/AGenericDrugPolicy.pdf, accessed 19 February 2013.
13. Meng, Q. (2010) Trends in access to health services and financial protection in China between 2003 and 2011: A cross-sectional study. Lancet 3379(9818): 805-814.
14. Ministry of Health of China. (2008) The Fourth National Health Services Survey. Beijing, China: Ministry of Health.
15. Sun, Q. (2004) A survey of medicine prices, availability, affordability and price components in Shandong province, China, http://www.haiweb.org/ medicineprices/surveys.php, accessed 3 March 2012.
16. Ye, L. (2006) A survey of medicine prices, availability and affordability in Shanghai, China using the WHO/HAI methodology research report, http://www.haiweb.org/medicineprices/surveys.php, accessed 3 March 2012.
17. Yang, S. and Fang, Y. (2010) Medicine prices, availability and affordability survey in Shaanxi province, Western China, http://www.haiweb.org/ medicineprices/surveys.php, accessed 3March 2012.
18. Liu, L. and Lu, H. (2010) Technology development through pooling ARV drug patents: Avision from China. Open AIDS J 4(1): 54-59.
19. Me'decins Sans Frontie'res. (2008) Untangling theWeb of Antiretroviral Price Reductions: 11th Edition. Geneva, Switzerland: Me'decins Sans Frontie'res, http://d2pd3b5abq75bb.cloudfront .net/2012/07/16/14/49/04/691/UTW-11-ENG- Jul2008.pdf, accessed 19 February 2013.
20. Hu, Y. (2010) Responses from HU Yuanqiong, China access to medicines research group. Speech to Informal Interactive Hearings of the General Assembly with Non-governmental organizations, Civil society organizations and the Private sector, New York, 14-15 June.
21. SFDA. (2010) Yearbook of statistics, http://www.sda.gov.cn/WS01/CL0108/ 66530.html, accessed 10 March 2012.
22. SFDA. (2010) Annual report on drug registration approval, http://www.sda.gov.cn/WS01/CL0236/65856.html, accessed 10 March 2012.
23. Chinese Pharmaceutical Enterprises Association. (2009) China Pharmaceutical Industry Development Report (1949-2009). Beijing, China: Chemical Industry Press.
24. Sudip, C. (2007) Is product patent protection necessary in developing countries for innovation? R&D by Indian Pharmaceutical Companies after TRIPS, http://ictsd.org/downloads/2008/04/sudip-wp-india-rd-trips-sept-2007.pdf, accessed 10 March 2012.
25. Li, X. (2008) Higher standards of patent protection and pharmaceutical industry - A comparative study on China and India. The World Economy 31(10): 1367-1382.
26. Wu, S., Hang, S., Chen, J. and Shi, L. (2012) Impact of medical data protection on drug expenditure and accessibility in China. Chinese Journal of New Drugs 21(20): 2353-2355.
27. Benjamin, P.L. (2012) Fighting poison with poison? The Chinese experience with pharmaceutical patent linkage. John Marshall Review of Intellectual Property Law 11(3): 623-672.
28. Zhang, L., Song, R. and Chen, C. (2006) Solving patent problem in the registration and approval of drugs. China Pharmacy 17(9): 644-650.
29. Fink, C. and Carlos, C. (2008) The global debate on the enforcement of intellectual property rights and developing countries. Geneva: ICTSD, Issue Paper 22.
30. Thomas, A.F. and Joel, L. (2007) 'Linkage' pharmaceutical evergreening in Canada and Australia. Australia and New Zealand Health Policy 4(6): 8.
31. China AIDS Info. (2008) China-Arv access fact sheet, http://www. chinaaids.org/english/factsheet-ARV.htm, accessed 23 March 2012.